Vontobel Holding Ltd. Annexon, Inc. Transaction History

Vontobel Holding Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jun 03, 2024	SELL	$1.63 - $4.63 $404,034 - $1.15 Million	-247,874 Reduced 27.58%	650,911 $2.96 Million
Q4 2023 Jan 29, 2024	SELL	$1.63 - $4.63 $404,034 - $1.15 Million	-247,874 Reduced 27.58%	650,911 $2.96 Million
Q3 2023 Jun 03, 2024	BUY	$2.13 - $3.84 $477,452 - $860,759	224,156 Added 33.23%	898,785 $2.12 Million
Q3 2023 Oct 10, 2023	BUY	$2.13 - $3.84 $477,452 - $860,759	224,156 Added 33.23%	898,785 $2.12 Million
Q2 2023 Jun 03, 2024	BUY	$2.1 - $6.37 $718,878 - $2.18 Million	342,323 Added 103.01%	674,629 $2.37 Million
Q2 2023 Jul 24, 2023	BUY	$2.1 - $6.37 $718,878 - $2.18 Million	342,323 Added 103.01%	674,629 $2.37 Million
Q1 2023 Jun 03, 2024	BUY	$3.74 - $7.46 $1.24 Million - $2.48 Million	332,306 New	332,306 $1.28 Million
Q1 2023 Apr 12, 2023	BUY	$3.74 - $7.46 $1.24 Million - $2.48 Million	332,306 New	332,306 $1.28 Million

158

101M

3.61M

1.08M

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $332M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

Stay updated on Vontobel Holding Ltd. with notifications on news.